Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 5/20 | 0.34 |
| ▸ | CA2 | P00918 | 5/20 | 0.34 |
| ▸ | CA9 | Q16790 | 5/20 | 0.34 |
| ▸ | CA12 | O43570 | 1/20 | 0.34 |
| ▸ | CA3 | P07451 | 1/20 | 0.34 |
| ▸ | CA4 | P22748 | 1/20 | 0.34 |
| ▸ | CA6 | P23280 | 1/20 | 0.34 |
| ▸ | CA5A | P35218 | 1/20 | 0.34 |
| ▸ | CA7 | P43166 | 1/20 | 0.34 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.34 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.34 |
| ▸ | ERN1 | O75460 | 4/20 | 0.33 |
| ▸ | P4HB | P07237 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31035400 | 0.83 | ERN1 (0.37) | CA1CA2CA9CA12CA3 | |
| SCHEMBL31035690 | 0.82 | LPL (0.35) | CA1CA2CA9CA12CA3 | |
| SCHEMBL15756969 | 0.80 | CYP3A4 (0.39) | CA1CA2CA9CA12CA3 | |
| SCHEMBL31035529 | 0.79 | CA1 (0.33) | CA1CA2CA9CA12CA3 | |
| SCHEMBL31035610 | 0.79 | CA1 (0.40) | CA1CA2CA9CA12CA3 | |
| SCHEMBL31035129 | 0.78 | CA1 (0.36) | CA1CA2CA9CA12CA3 | |
| SCHEMBL16815251 | 0.74 | JAK2 (0.35) | CA1CA2CA9CA12CA3 | |
| SCHEMBL31035250 | 0.74 | LPL (0.32) | — | |
| SCHEMBL16815579 | 0.73 | LPL (0.32) | CA1CA2CA9CA12CA3 | |
| SCHEMBL16044150 | 0.73 | LPL (0.35) | CA1CA2CA9CA12CA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4680612-A1 | CHEMICAL COMPOUNDS | AN2 Therapeutics, Inc. (US) | 2026-01-21 | — | — | EP | disclosed |
| WO-2024192309-A1 | CHEMICAL COMPOUNDS | REACTIVE BIOSCIENCES, INC. (US) | 2024-09-19 | — | — | WO | disclosed |